Article
OPA3 mutation screening in patients with unexplained 3-methylglutaconic aciduria.
Journal of inherited metabolic disease - 1 Jan 2005
Neas K, Bennetts B, Carpenter K, White R, Kirk E P, Wilson M, Kelley R, Baric I, Christodoulou J
Abstract excerpt
We have screened 13 patients with neurological abnormalities and 3-methylglutaconic aciduria (3MGA) for mutations in the OPA3 gene, which are known to be the cause of Costeff syndrome (optic atrophy, chorea and spasticity; type III 3MGA). We aimed to explore whether mutations in the OPA3 gene are present in patients with 3MGA but without classic Costeff syndrome. OPA3 mutations (IVS1-1G>C) were identified in 2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
